HYL.BR
Price:
$5.9
Market Cap:
$165.20M
Hyloris Pharmaceuticals SA engages in the develop, manufacture, and deliver pharmaceutical products to address unmet medical needs in cardiovascular health, oncology, women's health, and other major therapeutic areas. The company offers cardiovascular products for atrial fibrillation, acute coronary syndrome, advanced heart failure, congestive heart failure, acute coronary syndrome, and coronary heart disease. It also provides other products, such as post operation pain, dental indications, severe and recurring vulvovaginal candidiasis, acute myeloid leukemia and small cell lung cancer, IC/PBS, attention deficit hyperactivity disorder, and viral infection. Hyloris Pharmaceuticals SA was inco...[Read more]
Industry
Biotechnology
IPO Date
2020-06-29
Stock Exchange
BRU
Ticker
HYL.BR
According to Hyloris Pharmaceuticals S.A.’s latest financial reports and current stock price. The company's current PE Ratio is -24.58. This represents a change of -11.73% compared to the average of -27.85 of the last 4 quarters.
The mean historical PE Ratio of Hyloris Pharmaceuticals S.A. over the last ten years is -30.06. The current -24.58 PE Ratio has changed 8.08% with respect to the historical average. Over the past ten years (40 quarters), HYL.BR's PE Ratio was at its highest in in the June 2021 quarter at -10.89. The PE Ratio was at its lowest in in the June 2019 quarter at -105.48.
Average
-30.06
Median
-29.95
Minimum
-65.83
Maximum
0
Discovering the peaks and valleys of Hyloris Pharmaceuticals S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 248.65%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -65.83
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -29.95 | 29.02% |
| 2023 | -23.21 | -12.41% |
| 2022 | -26.50 | -31.34% |
| 2021 | -38.60 | 12.39% |
| 2020 | -34.34 | 248.65% |
| 2019 | -9.85 | -76.69% |
| 2018 | -42.26 | -35.81% |
| 2017 | -65.83 | -Infinity% |
The current PE Ratio of Hyloris Pharmaceuticals S.A. (HYL.BR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-26.55
5-year avg
-30.52
10-year avg
-30.06
Hyloris Pharmaceuticals S.A.’s PE Ratio is less than Onward Medical N.V. (-4.83), less than Celyad Oncology S.A. (-1.17), less than European Medical Solutions (35.81), less than BioSenic S.A. (-0.25), less than Oxurion N.V. (0.03), less than Sequana Medical N.V. (-0.54), less than Ion Beam Applications S.A. (21.06),
| Company | PE Ratio | Market cap |
|---|---|---|
| -4.83 | $186.58M | |
| -1.17 | $8.17M | |
| 35.81 | $19.56M | |
| -0.25 | $1.50M | |
| 0.03 | $450.71K | |
| -0.54 | $51.97M | |
| 21.06 | $358.49M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hyloris Pharmaceuticals S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hyloris Pharmaceuticals S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Hyloris Pharmaceuticals S.A.'s PE Ratio?
How is the PE Ratio calculated for Hyloris Pharmaceuticals S.A. (HYL.BR)?
What is the highest PE Ratio for Hyloris Pharmaceuticals S.A. (HYL.BR)?
What is the 3-year average PE Ratio for Hyloris Pharmaceuticals S.A. (HYL.BR)?
What is the 5-year average PE Ratio for Hyloris Pharmaceuticals S.A. (HYL.BR)?
How does the current PE Ratio for Hyloris Pharmaceuticals S.A. (HYL.BR) compare to its historical average?